Beam Therapeutics Inc.
MX ˙ BMV ˙ US07373V1052
SecurityMX:BEAM / Beam Therapeutics Inc.
InstitutionDeutsche Bank Ag\
Latest Disclosed Ownership87,141 shares
Latest Disclosed Value $ 2,076,570
Deutsche Bank Ag\ reports 12.35% increase in ownership of BEAM / Beam Therapeutics Inc.

On May 6, 2026 - Deutsche Bank Ag\ filed a 13F-HR form disclosing ownership of 87,141 shares of Beam Therapeutics Inc. (MX:BEAM) valued at $2,076,570 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 77,564 shares of Beam Therapeutics Inc.. This represents a change in shares of 12.35% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F BEAM THERAPEUTICS COM 07373V105 87,141 9,577 12.35 2,077 -3.44 0.0001
2026-02-11 2025-12-31 13F BEAM THERAPEUTICS COM 07373V105 77,564 4,649 6.38 2,150 21.54 0.0007
2025-11-13 2025-09-30 13F BEAM THERAPEUTICS COM 07373V105 72,915 8,127 12.54 1,770 60.53 0.0006
2025-08-12 2025-06-30 13F BEAM THERAPEUTICS COM 07373V105 64,788 -11,523 -15.10 1,102 -26.04 0.0004
2025-05-09 2025-03-31 13F BEAM THERAPEUTICS COM 07373V105 76,311 8,803 13.04 1,490 -10.99 0.0006
2025-06-30 2024-12-31 13F/A-1 BEAM THERAPEUTICS COM 07373V105 67,508 23,871 54.70 1,674 56.59 0.0007
2025-02-14 2024-12-31 13F BEAM THERAPEUTICS COM 07373V105 67,508 23,871 1,674 0.0007
2025-06-26 2024-09-30 13F/A-1 BEAM THERAPEUTICS COM 07373V105 43,637 -818,356 -94.94 1,069 -94.71 0.0004
2024-11-13 2024-09-30 13F BEAM THERAPEUTICS COM 07373V105 43,637 -818,356 1,069 0.0004
2025-06-12 2024-06-30 13F/A-1 BEAM THERAPEUTICS COM 07373V105 861,993 801,238 1,318.80 20,196 906.28 0.0091
2024-08-14 2024-06-30 13F BEAM THERAPEUTICS COM 07373V105 861,993 801,238 20,196 0.0091
2025-06-02 2024-03-31 13F/A-1 BEAM THERAPEUTICS COM 07373V105 60,755 3,800 6.67 2,007 29.48 0.0009
2024-05-15 2024-03-31 13F BEAM THERAPEUTICS COM 07373V105 60,755 3,800 2,007 0.0009
2024-02-14 2023-12-31 13F BEAM THERAPEUTICS COM 07373V105 56,955 156 0.27 1,550 13.47 0.0008
2023-11-24 2023-09-30 13F/A-1 BEAM THERAPEUTICS COM 07373V105 56,799 4,381 8.36 1,366 -18.35 0.0009
2023-11-09 2023-09-30 13F BEAM THERAPEUTICS COM 07373V105 56,799 4,381 1,366 0.0002
2023-08-14 2023-06-30 13F BEAM THERAPEUTICS COM 07373V105 52,418 -13,612 -20.61 1,674 -17.22 0.0009
2023-05-15 2023-03-31 13F BEAM THERAPEUTICS COM 07373V105 66,030 13,629 26.01 2,022 -1.37 0.0011
2023-02-13 2022-12-31 13F BEAM THERAPEUTICS COM 07373V105 52,401 2,046 4.06 2,049 -14.59 0.0012
2022-11-14 2022-09-30 13F BEAM THERAPEUTICS COM 07373V105 50,355 1,335 2.72 2,399 26.46 0.0014
2022-08-11 2022-06-30 13F BEAM THERAPEUTICS COM 07373V105 49,020 3,816 8.44 1,897 -26.76 0.0011
2022-05-13 2022-03-31 13F BEAM THERAPEUTICS COM 07373V105 45,204 -2,966 -6.16 2,590 -32.52 0.0012
2022-02-16 2021-12-31 13F/A-1 BEAM THERAPEUTICS COM 07373V105 48,170 426 0.89 3,838 -7.61 0.0017
2022-02-11 2021-12-31 13F BEAM THERAPEUTICS COM 07373V105 48,170 426 3,838 0.0002
2021-11-04 2021-09-30 13F BEAM THERAPEUTICS COM 07373V105 47,744 16,650 53.55 4,154 3.80 0.0020
2021-08-11 2021-06-30 13F BEAM THERAPEUTICS COM 07373V105 31,094 -26,473 -45.99 4,002 -13.15 0.0019
2021-05-13 2021-03-31 13F BEAM THERAPEUTICS COM 07373V105 57,567 26,762 86.88 4,608 83.29 0.0025
2021-02-16 2020-12-31 13F BEAM THERAPEUTICS COM 07373V105 30,805 11,571 60.16 2,514 431.50 0.0015
2020-11-12 2020-09-30 13F BEAM THERAPEUTICS COM 07373V105 19,234 13,058 211.43 473 173.41 0.0003
2020-08-13 2020-06-30 13F BEAM THERAPEUTICS COM 07373V105 6,176 1,776 40.36 173 118.99 0.0001
2020-05-14 2020-03-31 13F BEAM THERAPEUTICS COM 07373V105 4,400 4,400 79 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.